WIPO Virtual Workshop on The Determinants of COVID-19 Vaccine Development Success

This virtual workshop, organized by the World Intellectual Property Organization (WIPO) on May 5, 2022, will present the Study The Determinants of COVID-19 Vaccine Development Success, by Ms. Rena M. Conti, Associate Professor in the Department of Markets, Public Policy and Law and Co-director of the Technology Policy and Research Institute at the Boston University Questrom School of Business. Ms. Conti looked at a number of select case studies and found that vaccine success or failure result from a variety of determinants that work together. The study highlights particularly the importance of research and manufacturing collaboration, political will, funding, among many other factors. The study was designed to provide academic insights in order to stimulate thinking and incentivize further discussion.

The peer reviewers, Ms. Shanelle Hall, former Assistant Secretary General at UNICEF/UN and founder of “The Yellow House” consultancy firm, and Mr. Axel Metzger, Professor of Civil Law and Intellectual Property at Humboldt-University in Berlin, will comment the study. The workshop will then move to a panel discussion with further contributions from Mr. Carsten Fink, Chief Economist at WIPO, Mr. Martin Friede, Unit Head, Product and Delivery Research, Immunization, Vaccines and Biologicals Department at the World Health Organization (WHO) and Ms. Deborah King, Vaccine Research Lead, Vaccines Priority Area at the Wellcome Trust. The workshop will serve as a forum for exchange of views and will conclude with an open discussion session among all panelists and an opportunity for questions from the audience.

The workshop is open to the interested public. The workshop wasbe held in virtual format and in English only.

Meeting codeWIPO/GC/COVID-19/GE/22
Date and venueMay 5, 2022 (Geneva, Switzerland)
Related linksWIPO Virtual Workshop examines “The Determinants of COVID-19 Vaccine Development Success” study during its launch: English
Topic(s)Workshops and Seminars

Meeting documents

CodeTitle(s)File(s)
WIPO/GC/COVID-19/GE/22/1 PROV.EnglishProvisional AgendaProvisional Agenda, Complete document (pdf)

Other related documents

Title(s)File(s)
WIPO/GC/COVID-19/GE/22/P1EnglishPresentation – Prof. Rena ContiPresentation – Prof. Rena Conti, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P2EnglishPresentation – Ms. Shanelle HallPresentation – Ms. Shanelle Hall, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P3EnglishPresentation – Prof. Axel MetzgerPresentation – Prof. Axel Metzger, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P5EnglishPresentation – Mr. Martin FriedePresentation – Mr. Martin Friede, Complete document (pdf)
WIPO/GC/COVID-19/GE/22/P6EnglishPresentation – Ms. Deborah King (PDF)
See also: Covid-19 vaccines report from the Wellcome Trust (HTML)
Presentation – Ms. Deborah King (PDF)<br>See also: Covid-19 vaccines report from the Wellcome Trust (HTML), Complete document (htm) Presentation – Ms. Deborah King (PDF)<br>See also: Covid-19 vaccines report from the Wellcome Trust (HTML), Complete document (pdf)
WIPO/GC/COVID-19/GE/22/WWW/572491EnglishStudy by Rena Conti and comments by Shanelle Hall and Axel Metzger - The Determinants of COVID-19 Vaccine Development SuccessStudy by Rena Conti and comments by Shanelle Hall and Axel Metzger - The Determinants of COVID-19 Vaccine Development Success, Complete document (pdf)